PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28760780-7	2017	In contrast, NS309 sits more "forward" and directly hydrogen bonds with R362 in KCa3.1.	6,7-dichloro-1H-indole-2,3-dione 3-oxime	13-18	potassium calcium-activated channel subfamily N member 4	Homo sapiens	80-86	
27470924-3	2016	The channel expression was demonstrated as a significant increase in the voltage-independent current by NS309, a KCa 3.1/KCa 2 activator, followed by full inhibition upon co-application with NS6180, a highly selective KCa 3.1 inhibitor.	6,7-dichloro-1H-indole-2,3-dione 3-oxime	104-109	potassium calcium-activated channel subfamily N member 4	Homo sapiens	113-120	
27470924-3	2016	The channel expression was demonstrated as a significant increase in the voltage-independent current by NS309, a KCa 3.1/KCa 2 activator, followed by full inhibition upon co-application with NS6180, a highly selective KCa 3.1 inhibitor.	6,7-dichloro-1H-indole-2,3-dione 3-oxime	104-109	potassium calcium-activated channel subfamily N member 4	Homo sapiens	218-225	
34468723-7	2021	With the compound NS309, we mimic a gain-of-function mutation of KCa3.1.	6,7-dichloro-1H-indole-2,3-dione 3-oxime	18-23	potassium calcium-activated channel subfamily N member 4	Homo sapiens	65-71	
31415760-5	2019	KCa2.3-mediated vasodilatation responses to acetylcholine and NS309 (agonist of KCa2.3 and KCa3.1) were impaired by incubation of normal mesenteric arteries with 100 muM PA for 24 h. In cultured human umbilical vein endothelial cells (HUVECs), PA decreased KCa2.3 current and expression at mRNA and protein levels.	6,7-dichloro-1H-indole-2,3-dione 3-oxime	62-67	potassium calcium-activated channel subfamily N member 4	Homo sapiens	91-97